Connect Biopharma is trading at $2.09 (+6.09%) following a broad risk-on move in U.S. equities and supportive macro sentiment.
- The move appears driven by broader market strength rather than company-specific catalysts, as index futures trend higher.
- Major indices are showing significant gains, with the S&P 500 up 1.00% and the Nasdaq Composite rising 1.55%.
- Small-cap biotech shares are catching a bid as investors rotate back into riskier assets amid the improved market backdrop.